Latest News
Point d'activité
Thursday, 21 July 2016 00:00

Résultats encourageants des essais d'endurance à Morcenx,
Arrêt temporaire de la production à l'usine Inertam,
Avancement des projets bulgares et chinois conforme au planning.

[Lire le communiqué]

 
Europlasma annonce des évolutions au sein de sa gouvernance et dans sa structure de financement
Thursday, 21 July 2016 00:00

Démission de Crédit Suisse Asset Management (CSAM) et mise en place d’un financement obligataire flexible par émission d’OCA et d’OCABSA pour un montant maximum d’emprunt obligataire de 15m€.

[Lire le communiqué]

 
The CHO TIPER project is approved by french authorities and receives a 12m€ support from ADEME
Wednesday, 13 July 2016 00:00

The CHO TIPER renewable energy plant is approved by French authorities, and is financially supported by Ademe as part of the “Investissements d’Avenir” programme

[Read the press release]

 
Report on liquidity contract as at 30 June 2016
Tuesday, 05 July 2016 00:00

Under the liquidity contract entrusted by Kepler Cheuvreux, the following assets appeared on the liquidity account at 30 June 2016:

  • 141,014 shares
  • €18,129.41

[Read the press release]

 
Renewal eligibility for the French PEA-PME regime
Thursday, 30 June 2016 00:00

Europlasma is eligible for the French PEA-PME regime [Read the press release]

 
Filing of the 2015 Registration Document
Thursday, 28 April 2016 00:00

Europlasma announces that its 2015 Registration Document has been filed with the French "Autorité des Marchés Financiers" (AMF). [Read the press release]

 
2015 annual results and highlights
Thursday, 21 April 2016 00:00

Europlasma announces its results for the year ended 31 December 2015.

At consolidated level:
  • First results from the strategic shift: a significant improvement in sales and operating performance in each of the Group's three divisions.
    • Revenues of €14.1 million, up 57% on 2014, driven by growth in each of the sectors.
    • Net loss of €16.2 million, reduced by 38%.

At divisional level:

  • Positive contribution of Plasma Solutions (excluding Corporate costs) and Asbestos treatment to the Group EBITDA level.
  • Major progress for the Renewable Energies division, which obtained the Final Acceptance with Reserves (FAR), opening the way for the final delivery.

 [Read the press release]

 
Appointment of a new Director
Wednesday, 20 April 2016 00:00

Europlasma announces the appointment of Yann Le Doré as independent Director. [Read the press release]

 
2015 Turnover and implementation of equity line financing
Thursday, 25 February 2016 00:00

Europlasma announces its 2015 turnover, outlines its financial position and establishes new equity line financing to fund growth in 2016.

  • 2015 consolidated revenue: up 57% year-on-year to €14.1 million, with robust growth in all three group divisions.
  • Strengthened and diversified sources of financing to meet cash requirements until the end of 2016 with a view to supporting its development.
  • Implementation of equity line financing for a maximum amount of €10 million with Kepler Cheuvreux.
 
Information note: details relative to BSAR
Monday, 08 February 2016 00:00

Following several questions from redeemable warrants holders, the company would point out:

  • the conditions of the eligibility for the ISF-PME tax reduction
  • the conditions of the early redemption clause

[Read the note] (in French)

 

 
Order of engines for the CHO Morcenx power plant
Monday, 25 January 2016 00:00

Europlasma announces the order of the additional engines for the CHO Morcenx power plant, funded under attractive terms. [Read the press release]

 
HY report as at 31/12/2015 on liquidiy contract
Thursday, 07 January 2016 10:16

Under the liquidity contract entrusted by Kepler Cheuvreux, the following assets appeared on the liquidity account at 31 December 2015: [Read the press release]

 


Contact Us

Headquarter

471 Route de Cantegrit - BP 23
40 110 Morcenx
France

Offices

11 avenue de Canteranne - Cité Photonique - Bât. Sirah
33600 Pessac
France
Tel : + 33 (0)5 56 49 70 00
Fax : + 33 (0)5 56 49 70 19

Financial News

13/07/2016 - 12m€ support from ADEME
[Read more]